• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Leveraging Injection Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject Drugs in Kenya: Design and Rationale.利用注射网络预防肯尼亚注射吸毒者中的艾滋病毒和其他血液传播感染:设计与原理
Res Sq. 2025 Aug 20:rs.3.rs-7401891. doi: 10.21203/rs.3.rs-7401891/v1.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
4
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.针具交换计划和阿片类药物替代疗法预防注射吸毒者丙型肝炎传播
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2.
5
Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs-A network modeling study.针对注射吸毒人群的丙型肝炎消除的治疗和预防干预措施的潜在影响——网络建模研究。
Int J Drug Policy. 2024 Aug;130:104539. doi: 10.1016/j.drugpo.2024.104539. Epub 2024 Jul 20.
6
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.全球、区域和国家层面预防和管理注射吸毒人群中艾滋病毒和丙型肝炎的干预措施的覆盖情况:系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1208-e1220. doi: 10.1016/S2214-109X(17)30373-X. Epub 2017 Oct 23.
7
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况:多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
8
Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA.建立模型,以评估美国加利福尼亚州三个县中的监管吸毒点对注射吸毒者中的 HIV 和 HCV 传播的影响。
Int J Drug Policy. 2024 Oct;132:104557. doi: 10.1016/j.drugpo.2024.104557. Epub 2024 Aug 29.
9
Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.在伊朗的一次社区咨询中,探讨了影响注射吸毒人群参与和保留 HIV/HCV 队列研究的障碍和促进因素。
Subst Abuse Treat Prev Policy. 2020 Aug 5;15(1):56. doi: 10.1186/s13011-020-00298-y.
10
HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.中东和北非地区注射吸毒者中的艾滋病毒:系统评价与数据综合
PLoS Med. 2014 Jun 17;11(6):e1001663. doi: 10.1371/journal.pmed.1001663. eCollection 2014 Jun.

本文引用的文献

1
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya.扩大减少伤害干预措施对肯尼亚注射吸毒者的注射风险行为、抗逆转录病毒治疗结果及艾滋病毒发病率的影响。
Int J Drug Policy. 2025 Jun;140:104824. doi: 10.1016/j.drugpo.2025.104824. Epub 2025 May 5.
2
Inferring bivariate associations with continuous data from studies using respondent-driven sampling.利用应答者驱动抽样法从研究中推断连续数据的双变量关联。
J R Stat Soc Ser C Appl Stat. 2024 Nov 26;74(2):429-446. doi: 10.1093/jrsssc/qlae061. eCollection 2025 Mar.
3
Widespread hepatitis C virus transmission network among people who inject drugs in Kenya.肯尼亚注射吸毒者中广泛存在的丙型肝炎病毒传播网络。
Int J Infect Dis. 2024 Oct;147:107215. doi: 10.1016/j.ijid.2024.107215. Epub 2024 Sep 7.
4
Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data, 2010-23.撒哈拉以南非洲关键人群的人口规模、艾滋病毒流行率和抗逆转录病毒治疗覆盖率:2010-2023 年调查数据的整理和综合。
Lancet Glob Health. 2024 Sep;12(9):e1400-e1412. doi: 10.1016/S2214-109X(24)00236-5.
5
Network-based strategies to combat HCV: Examining social and spatial drivers of transmission among PWID in New Delhi.基于网络的丙型肝炎病毒防治策略:探究新德里注射吸毒者之间传播的社会和空间驱动因素。
J Viral Hepat. 2024 Sep;31(9):535-543. doi: 10.1111/jvh.13960. Epub 2024 Jun 4.
6
Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India.注射网络驱动因素对注射吸毒者预防服务利用的影响:印度新德里基于社区的社会计量网络队列研究结果。
J Int AIDS Soc. 2024 Apr;27(4):e26241. doi: 10.1002/jia2.26241.
7
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.丙型肝炎感染的直接抗病毒疗法:全球注册、报销及限制情况
Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15.
8
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.全球、区域和国家层面在注射吸毒人群中开展 HIV 和丙型肝炎感染检测和治疗的情况:系统评价。
Lancet Glob Health. 2023 Dec;11(12):e1885-e1898. doi: 10.1016/S2214-109X(23)00461-8.
9
Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India.网络中心度与注射吸毒者的艾滋病预防服务利用:来自印度新德里社会计量网络队列的研究结果。
Addiction. 2024 Mar;119(3):570-581. doi: 10.1111/add.16379. Epub 2023 Nov 15.
10
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.全球范围内预防和管理注射吸毒者药物相关危害的干预措施覆盖情况:系统评价。
Lancet Glob Health. 2023 May;11(5):e673-e683. doi: 10.1016/S2214-109X(23)00058-X. Epub 2023 Mar 27.

利用注射网络预防肯尼亚注射吸毒者中的艾滋病毒和其他血液传播感染:设计与原理

Leveraging Injection Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject Drugs in Kenya: Design and Rationale.

作者信息

Akiyama Matthew J, Manley Hannah N, Riback Lindsey R, Zhang Chenshu, Alvandi Amirhossein, Gile Krista, Jiang Yun, Nyakowa Mercy, Ganatra Nazila, Bashir Issak, Coleman Ewan, Stone Jack, Vickerman Peter, Walker Josephine G

机构信息

Albert Einstein College of Medicine.

University of Massachusetts.

出版信息

Res Sq. 2025 Aug 20:rs.3.rs-7401891. doi: 10.21203/rs.3.rs-7401891/v1.

DOI:10.21203/rs.3.rs-7401891/v1
PMID:40894059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393469/
Abstract

BACKGROUND

HIV and Hepatitis C (HCV) are blood borne infections (BBIs) that remain a significant cause of global morbidity and mortality among people who inject drugs (PWID). UNAIDS and WHO have set goals for the elimination of viral hepatitis and HIV as major public health threats by 2030. To achieve these targets, innovative strategies are required among marginalized populations such as PWID, especially in resource-limited countries where coverage of harm reduction services is often limited. The goal of this study is to inform targeted strategies to prevent transmission of BBIs among PWID.

METHODS

We will use respondent driven sampling (RDS) to recruit PWID from needle and syringe programs in Kenya. Participants will complete biobehavioral and social network surveys and receive point-of-care HCV, HIV, and hepatitis B (HBV) testing. Participants will return for at least one follow-up visit to complete additional surveys and testing. We will use network data from RDS, egocentric, and viral phylogenetics to identify how highly central PWID contribute to transmission networks and use mathematical modelling to investigate the impact of targeted interventions based on network characteristics.

DISCUSSION

This study will provide important information for policymakers and researchers designing strategies for BBI elimination. Network- and molecular epidemiologic-informed tools to guide targeted strategies may be critical to maximizing the impact of treatment and prevention efforts in resource-limited settings. This approach may provide a durable template for future studies, including prospective assessments of targeted prevention and elimination strategies among PWID, and assist with monitoring elimination progress in resource-limited settings.

摘要

背景

艾滋病毒和丙型肝炎(HCV)是通过血液传播的感染性疾病,在注射吸毒者(PWID)中仍然是全球发病和死亡的重要原因。联合国艾滋病规划署(UNAIDS)和世界卫生组织(WHO)已设定目标,到2030年消除病毒性肝炎和艾滋病毒这两大主要公共卫生威胁。为实现这些目标,需要在注射吸毒者等边缘化人群中采取创新策略,尤其是在资源有限的国家,这些国家减少伤害服务的覆盖范围往往有限。本研究的目的是为预防注射吸毒者中血液传播感染性疾病传播的针对性策略提供信息。

方法

我们将采用应答驱动抽样(RDS)方法,从肯尼亚的针头和注射器项目中招募注射吸毒者。参与者将完成生物行为和社会网络调查,并接受即时检验的丙型肝炎病毒、艾滋病毒和乙型肝炎病毒(HBV)检测。参与者将返回进行至少一次随访,以完成额外的调查和检测。我们将使用来自应答驱动抽样、自我中心网络和病毒系统发育学的网络数据,以确定处于高度中心地位的注射吸毒者如何对传播网络产生影响,并使用数学模型来研究基于网络特征的针对性干预措施的影响。

讨论

本研究将为政策制定者和研究人员设计消除血液传播感染性疾病的策略提供重要信息。利用网络和分子流行病学的工具来指导针对性策略,对于在资源有限的环境中最大限度地提高治疗和预防工作的效果可能至关重要。这种方法可能为未来的研究提供一个持久的模板,包括对注射吸毒者中针对性预防和消除策略的前瞻性评估,并有助于监测资源有限环境中的消除进展情况。